Computational Protein Design to Reengineer Stromal Cell–Derived Factor-1α Generates an Effective and Translatable Angiogenic Polypeptide Analog
Author(s) -
William Hiesinger,
Jose Manuel PerezAguilar,
Pavan Atluri,
Nicole A. Marotta,
John R. Frederick,
J. Raymond Fitzpatrick,
Ryan C. McCormick,
Jeffrey R. Muenzer,
Elaine Yang,
Rebecca D. Levit,
Lijun Yuan,
John W. MacArthur,
Jeffery G. Saven,
Y. Joseph Woo
Publication year - 2011
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.110.009431
Subject(s) - stromal cell , protein kinase b , medicine , progenitor cell , angiogenesis , growth factor , stem cell , phosphorylation , microbiology and biotechnology , cancer research , receptor , biology
Experimentally, exogenous administration of recombinant stromal cell-derived factor-1α (SDF) enhances neovasculogenesis and cardiac function after myocardial infarction. Smaller analogs of SDF may provide translational advantages including enhanced stability and function, ease of synthesis, lower cost, and potential modulated delivery via engineered biomaterials. In this study, computational protein design was used to create a more efficient evolution of the native SDF protein.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom